Pancreaticopleural fistula in a child with chronic pancreatitis harboring compound SPINK1 variants

Teera Kijmassuwan1, Prapun Aanpreung2, Varayu Prachayakul3

  • 1Division of Gastroenterology, Department of Pediatrics, Siriraj Hospital, Mahidol University, Bangkok, Thailand. teera.kij@mahidol.edu.

BMC Gastroenterology
|June 13, 2021
PubMed

Insights

Pancreaticopleural fistula (PPF) is a rare complication of chronic pancreatitis. This case highlights successful endoscopic stent management for a child with PPF, emphasizing early diagnosis and intervention.

Area of Science:

  • Gastroenterology
  • Pulmonology
  • Pediatric Medicine

Background:

  • Pancreaticopleural fistula (PPF) is a rare complication of chronic pancreatitis (CP).
  • Diagnosis requires high clinical suspicion in patients with unexplained pleural effusion.
  • Radiological imaging is crucial for confirming the fistula tract.

Observation:

  • A 9-year-old boy with massive right pleural effusion due to PPF, secondary to CP with SPINK1 mutations.
  • Conservative treatments failed.

Findings:

  • Successful management of pediatric PPF using endoscopic pancreatic duct stent placement.
  • High pleural fluid amylase and MRCP are key diagnostic tools.
  • Endoscopic therapy is effective after conservative treatment failure.

Implications:

  • PPF is a serious complication across all age groups.
  • Early diagnosis in children with pancreatic pathology and pleural effusion is vital.
  • Endoscopic therapy offers a viable treatment option for refractory PPF.
Abstract